You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
錦欣生殖:擴大深圳中山醫院控股權至99.9%,對價股份認購彰顯醫院管理層發展信心
格隆匯 04-13 23:34
格隆匯4月13日丨錦欣生殖宣佈附屬擬以1.28億元收購深圳中山醫院董事長曾勇所持深圳中山醫院5.46%的股份,對應估值23.5億人民幣;對應醫院2021年淨利潤,PE倍數為23倍。本次收購對價中的68%(9750萬港幣),實際以股份支付,後續公司將向曾勇定向增發公司股份;認購價為6.5港幣,較4月13日收盤價5.72港元溢價13.63%。通過股份支付方式,公司將充分綁定其個人和上市公司其他股東的利益,激勵其繼續支持醫院的發展。完成收購後,公司對深圳中山醫院的控股權至99.9%。考慮到對價支付以及歸屬於股東的淨利增加,預計將增厚公司業績。深圳中山醫院2021年疫情影響下仍然實現高速增長,週期數增長29%,收入增長42%。公司認為深圳醫院未來具有很大的增長空間,特別是考慮到大灣區內與香港的協同。鑑於深圳醫院的潛力,公司也與今年2月份為其購置新物業,預計2023年三季度投入運營。產能擴張後,深圳醫院在週期數,特需服務及新增業務將有更大空間。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account